Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust (REIT) established in 1991, specializing in sale-leasebacks, joint ventures, and both mortgage and mezzanine financing. The company's primary focus is on need-driven and discretionary senior housing and medical investments.
NHI's diverse portfolio comprises various types of facilities including independent living, assisted living, and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings, and specialty hospitals. The company operates through two main segments: Real Estate Investments and the Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment includes investments in real estate leases, mortgages, and other notes receivables related to independent living, assisted living, and skilled nursing facilities among others. The SHOP segment involves ventures that own and operate independent living facilities, realizing revenue from rental, mortgage interest income, and resident fees and services.
Financially, NHI has demonstrated resilience and growth. As of the end of 2023, NHI maintained a robust balance sheet with $1.1 billion in net debt and leverage at just 4.4 times net debt-to-adjusted EBITDA. This strong financial profile is enhanced by investment-grade credit ratings from Moody's, S&P Global, and Fitch Ratings. NHI's financial health was further highlighted by the company exceeding its 2023 guidance for NAREIT FFO, NFFO, and FAD.
Recent achievements include a successful fourth quarter in 2023 with over $2.0 million in deferral repayments, no unexpected rent concessions, and substantial growth in the SHOP segment. The company has continued this momentum into 2024, generating notable revenue growth and maintaining high occupancy rates across its facilities. Looking ahead, NHI has a pipeline exceeding $300 million, with a significant portion already under letters of intent, ensuring ongoing investment and growth opportunities.
In February 2024, NHI announced a new stock repurchase plan totaling $160 million, reflecting its commitment to returning value to shareholders. The company also maintains a substantial revolving credit facility, offering significant liquidity for future investments and operational needs.
Partnerships and Programs:
- Strategic partnerships with senior housing operators.
- Joint ventures for operational and financial synergy.
- Investment in high-yield real estate opportunities.
NHI’s commitment to long-term growth and stable financial health, combined with its strategic investment in senior housing and medical facilities, positions it as a vital player in the healthcare real estate market.
For more information, visit www.nhireit.com.
National Health Investors (NYSE:NHI) has appointed Candice Todd to its Board of Directors, effective January 1, 2025. Todd previously served as Managing Director/Global Chief Financial Officer of Morgan Stanley Real Estate Investments from 2019 until February 2023. She brings extensive experience in real estate investment and finance, having worked at Morgan Stanley since 1994 in various roles. Todd currently serves on the Board of Directors at Highwoods Properties (NYSE:HIW) as a financial expert and audit committee member. NHI's CEO Eric Mendelson expects her expertise to contribute to the company's internal and external growth objectives.
National Health Investors (NYSE:NHI) announced that W. Andrew 'Andy' Adams will retire as Chairman of the Board effective December 31, 2024, after more than 30 years of leadership. Adams founded the company in 1991 and served as President until February 2009 and CEO until March 2011. Under his leadership, the company has grown its healthcare real estate investment and senior housing operating portfolios to over $3.0 billion in total gross investments across 193 healthcare real estate properties, mortgages and other notes receivable.
National Health Investors (NYSE:NHI) has declared its fourth quarter dividend of $0.90 per common share. The dividend will be paid on January 29, 2025, to stockholders of record as of December 31, 2024.
National Health Investors (NYSE: NHI), a real estate investment trust, has issued an investor update. The company, incorporated in 1991, specializes in sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing for senior housing and medical investments. NHI's portfolio includes independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. The full investor update can be found at NHI's website under Presentations and Webcasts.
National Health Investors (NYSE:NHI) reported Q3 2024 results with net income per diluted share of $0.65, down from $0.68 in Q3 2023. Normalized FFO per share was $1.03, compared to $1.08 year-over-year. The company updated its 2024 guidance, revising NAREIT FFO to $4.39-$4.41 from $4.50-$4.54, primarily due to lower cash lease revenue and interest income assumptions.
Notable developments include $205.6 million in new investments in 2024 with an 8.4% average initial yield, and signed LOIs for another $59.8 million with an 8.8% average yield. The SHOP portfolio showed improvement with quarterly occupancy increasing 960 basis points year-over-year to 88.6%, and NOI increasing 30.4% year-over-year.
National Health Investors, Inc. (NYSE:NHI), a real estate investment trust specializing in senior housing and medical investments, has issued an investor update. The update is available on the company's website under the 'Presentations and Webcasts' section.
NHI, incorporated in 1991, focuses on various investment strategies in the healthcare sector, including sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing. The company's portfolio encompasses a range of healthcare facilities, such as independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
National Health Investors (NYSE:NHI) has announced the schedule for its third quarter 2024 earnings release and conference call. The company plans to release its financial results for the quarter ended September 30, 2024, after the market closes on Tuesday, November 5, 2024. NHI will host a conference call to discuss these results on Wednesday, November 6, 2024, at 11:00 a.m. Eastern Time.
Interested parties can join the interactive teleconference by calling (888) 506-0062 and using the access code 414723. A live broadcast of the conference call will also be available online at www.nhireit.com and https://www.webcaster4.com/Webcast/Page/633/51151. An online replay of the call will be accessible shortly after the event and remain available for one year.
National Health Investors (NYSE:NHI) has announced the pricing of an upsized public offering of 2,400,000 shares of common stock at $71.25 per share. The offering, expected to close on August 16, 2024, includes a 30-day option for underwriters to purchase up to 360,000 additional shares. NHI has entered into forward sale agreements with major financial institutions, allowing for future settlement within approximately 12 months. The company plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. This offering is made through an effective shelf registration statement and is being managed by leading investment banks.
National Health Investors (NYSE:NHI) has announced a public offering of 2,000,000 shares of its common stock. The offering includes a 30-day option for underwriters to purchase up to an additional 300,000 shares. NHI will enter into forward sale agreements with major financial institutions acting as forward purchasers. The company won't receive immediate proceeds from the sale but expects to settle the agreements within 12 months for cash. NHI plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. The offering is made under an effective shelf registration statement and will be conducted through a prospectus supplement and related documents available from the joint book-running managers: BofA Securities, J.P. Morgan, Wells Fargo Securities, and BMO Capital Markets.
National Health Investors (NYSE:NHI) has declared its third quarter 2024 dividend of $0.90 per common share. The dividend will be paid on November 1, 2024 to stockholders of record as of September 27, 2024. This announcement demonstrates NHI's commitment to providing regular returns to its shareholders, maintaining its dividend policy despite ongoing economic uncertainties. The consistency in dividend payments may be seen as a positive sign of the company's financial stability and confidence in its future performance.
FAQ
What is the current stock price of National Health Investors (NHI)?
What is the market cap of National Health Investors (NHI)?
What types of properties are included in NHI's portfolio?
How does NHI generate its revenue?
What are the main segments of NHI's operations?
How has NHI performed financially in recent years?
What recent achievements has NHI made?
What is the 2024 stock repurchase plan?
What are NHI's plans for future investments?
How does NHI maintain its financial stability?
Who comprises NHI’s primary tenant base?
How can investors learn more about NHI?
